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Cushing’s disease is rare in children and adolescents. We report the clinical presenta-
tions of three children with Cushing’s disease. All three exhibited the typical symptoms 
and signs of weight gain and growth retardation. Two also demonstrated personality 
changes, hypertension and hypokalemia, the last of these being rarely reported in 
patients with Cushing’s disease. Lack of diurnal changes in serum cortisol levels was 
the most common biochemical finding. Serum cortisol levels were suppressed by low-
dose dexamethasone in one patient, which is not typical for patients with Cushing’s 
disease. Imaging studies are essential for localizing the tumor. Transsphenoidal surgery 
remains the treatment of choice, and pituitary irradiation should be considered for 
those patients whose tumors cannot be totally removed. Careful follow-up of these 
patients with awareness of the possibilities of relapse and the complications of 
hypopituitarism is indicated.
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1.  Introduction
Cushing’s syndrome, or hypercortisolism, describes 
the clinical manifestations of glucocorticoid excess 
from any sources. Cushing’s disease specifically refers 
to hypercortisolism due to excessive adrenocorti-
cotropic hormone (ACTH) secretion from a pituitary 
adenoma.1 It is rare in children and adolescents.2,3 
The early presentations of hypercortisolism in chil-
dren are weight gain and growth failure.4−9 Other 
common symptoms include moon face, plethora, 
acne, hirsutism, striae, hypertension, puberty arrest, 
and personality changes.4−9 The last of these symp-
toms has been variably reported in children.3−7
Confirmation and differential diagnosis of 
Cushing’s disease is not an easy task, especially in 
children. Hypercortisolism is usually manifested by 
the lack of a normal circadian rhythm of cortisol 
secretion. The localization of lesions usually relies 
on imaging studies and the suppressibility of the 
hypothalamic-pituitary-adrenal axis by dexametha-
sone.2−6,9−14 The diagnosis and appropriate treatment 
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of these children may prevent future adult height 
deficits and osteopenia.9,15,16 Transsphenoidal pitui-
tary adenomectomy is the treatment of choice in 
these children, and a high cure rate has been re-
ported.3−6,8−10 Here, we report the clinical presen-
tations, diagnosis and treatment of three children 
with Cushing’s disease, which may help clinicians to 
make an early diagnosis in such patients.
2.  Case Report
2.1.  Case 1
This boy was diagnosed at the age of 12 years and 
9 months, with a history of rapid weight gain for 10 
months before admission. Insomnia, decreased appe-
tite, weight loss, depression, and regressive behavior 
had also been noted for 6 months before admission. 
He had been treated for depression with no improve-
ment in symptoms. An initial endocrine evaluation 
revealed some acne on his face, but neither moon 
face nor buffalo hump was noted. His growth rate 
was 1.1 cm/year during this period. He had a height 
of 148.6 cm (25−50th percentile), a weight of 34.3 kg 
(10−25th percentile) and blood pressure of 160/
110 mmHg. He had signs of puberty; both testes 
had volumes of 8 mL and pubic hair was at Tanner 
stage I. His bone age was between 12 years 6 months 
and 13 years.
Laboratory tests showed serum sodium of 
146 mmol/L, potassium of 2.4 mmol/L, and chloride 
of 101 mmol/L. His plasma ACTH level was 73.9 pg/
mL (16.3 pmol/L), and serum cortisol levels were 
43.3 μg/dL (1195 nmol/L) at 8 AM and 26.6 μg/dL 
(734 nmol/L) at 11 PM. His serum cortisol [> 50 μg/dL 
(> 1329 nmol/L)] was not suppressed by a low-dose 
dexamethasone suppression test (dexamethasone 
20 μg/kg/day); however, a subsequent high-dose 
dexamethasone suppression test (dexamethasone 
80 μg/kg/day) suppressed the patient’s serum cor-
tisol level to 26.1 μg/dL (720 nmol/L). Magnetic res-
onance imaging (MRI) of the sella turcica disclosed 
a 0.8-cm pituitary adenoma (Figure 1). The patient 
underwent transsphenoidal pituitary adenomectomy, 
and transient rhinorrhea of the cerebrospinal fluid 
was noted. An ACTH-secreting pituitary adenoma 
was confirmed by pathologic examination. The symp-
toms, including the psychological problems, improved 
gradually after surgery.
Unfortunately, recurrence of Cushing’s syn-
drome was noted 1 year after surgery, with symptoms 
of weight gain, moon face, and emotional instability. 
Transcranial tumor excision was performed 11 months 
later, and transient neurologic diabetes insipidus 
was noted postoperatively. Because residual tumor 
was detected after surgery, the patient underwent 
Figure 1 Magnetic resonance image of case 1. Coronal 
T1-weighted image with gadolinium enhancement showed 
a 0.8-cm pituitary adenoma.
radiotherapy with a total dose of 5000 cGy. The signs 
and symptoms improved, though panhypopituitarism 
was noted 4 years after the second operation and 
radiotherapy. The patient received continuing treat-
ment with eltroxin, cortisone acetate, and testos-
terone cypionate, with no evidence of recurrence 
after 13 years’ follow-up.
2.2.  Case 2
This girl presented at the age of 11 years and 3 
months. She had experienced rapid weight gain from 
31 kg to 65 kg, but had only grown by 7 cm in height in 
2 years. Acne and facial flushing were also noted. 
No previous medication had been prescribed. The 
patient had initially ignored the symptoms, but fre-
quent poor appetite, nausea, vomiting, and abdomi-
nal pain developed 6 months prior to attendance at 
our pediatric endocrine clinic. Moon face, buffalo 
hump, generalized obesity, and purpuric striae were 
noted. She had a height of 149.8 cm (75−90th percen-
tile), weight of 65 kg (above the 97th percentile), and 
blood pressure of 114/80 mmHg. Her breasts were 
Tanner stage III, and pubic hair was Tanner stage II. 
She had not yet undergone menarche. Her bone age 
was between 12 and 13 years.
Blood chemistry analysis demonstrated a lack of 
changes in diurnal serum cortisol levels, with 15.4 μg/
dL (425 nmol/L) at 8 AM and 15.2 μg/dL (419 nmol/L) 
at 8 PM. A low-dose dexamethasone suppression test 
reduced her serum cortisol levels from 23.45 μg/dL 
(647 nmol/L) to 0.29 μg/dL (8 nmol/L). However, 
MRI of the sella turcica showed a 0.5-cm mass at 
the left inferior adenohypophysis. Trans sphenoidal 
pituitary adenomectomy was performed, and pa-
thology revealed an ACTH-secreting adenoma, which 
was immunoreactive for ACTH by immunochemical 
stain (Figure 2). Transient central diabetes insipidus 
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and rhinorrhea of cerebral spinal fluid were noted 
postoperatively. However, the symptoms subsided 
after surgery, and there was no evidence of recur-
rence during 12 years’ follow-up.
2.3.  Case 3
A girl aged 10 years and 9 months experienced rapid 
weight gain from 23 kg to 36.4 kg, with an increase 
in height of only 3.5 cm in 2 years. No specific drugs 
had been prescribed previously. Although she had 
visited other hospitals, no diagnostic conclusion had 
been reached. She also experienced regressive be-
havior, depression, and poor school performance 
during this period. The patient presented at our 
outpatient clinic with a presentation of moon face 
with plethora, buffalo hump, acne over the face, and 
purpuric striae over her thighs. She had a height of 
122.5 cm (below the 3rd percentile), weight of 36.4 kg 
(50−75th percentile), and a blood pressure of 159/
109 mmHg. Her breasts were Tanner stage III and 
pubic hair was Tanner stage II, but she had not yet 
undergone menarche. Her bone age was 7 years and 
4 months. Blood chemistry analysis showed serum 
sodium, 141 mmol/L; potassium, 2.9 mmol/L; and 
chloride, 103 mmol/L.
A series of studies were performed under the 
impression of Cushing’s syndrome. The patient’s 
baseline endocrine data showed ACTH level to be 
41.4 pg/mL (9.11 pmol/L) in the morning, and serum 
cortisol levels of 28.2 μg/dL (778 nmol/L) at 9 AM and 
15.7 μg/dL (433 nmol/L) at 11 PM. The serum cortisol 
level was not suppressible [27.5 μg/dL (759 nmol/L)] 
by low-dose dexamethasone, but was suppressed to 
10.2 μg/dL (281 nmol/L) by high-dose dexametha-
sone. A 0.3-cm heterogeneously-enhanced tumor 
in the lower anterior pituitary gland was suspected on 
the basis of a brain MRI study (Figure 3). Trans-
sphenoidal pituitary adenomectomy was performed. 
The pathologic findings disclosed an ACTH-secreting 
pituitary adenoma. Transient neurologic diabetes 
insipidus was noted after surgery. She lost 9.1 kg 
over the following 10 months. All the symptoms 
subsided, but panhypopituitarism was confirmed 
8 months after surgery. She received treatment with 
growth hormone, eltroxin, and cortisone acetate 
and demonstrated normal growth after hormone re-
placement therapy. There was no evidence of recur-
rence after two and a half years’ follow-up.
3.  Discussion
Cushing’s disease is rare in children, and its clinical 
presentations differ from those in adults. In chil-
dren with Cushing’s disease, growth retardation may 
be an early and the most impressive sign.4−9 Other 
common presentations include obesity-associated 
moon face, buffalo hump, bruising striae, hirsutism, 
hypertension, and psychological disturbances.4−9 
Rapid weight gain and growth retardation were ob-
served in all three patients in this study. Psycho-
logical problems, such as depression and behavioral 
changes, may be the major complaints in children 
with Cushing’s disease. Two of our patients presented 
with such problems as initial symptoms. Thus a high 
index of suspicion of Cushing’s syndrome is essential 
for its diagnosis in children with obesity, retarded 
growth, and behavioral changes.
Two patients (cases 1 and 3) also presented with 
hypertension accompanied by marked hypokalemia. 
Hypokalemia is often reported in patients with ec-
topic ACTH syndrome and macroadenoma; potassium 
200 µm
Figure 2 Pathological examination of patient presented 
in case 2 showed nests of adenomatous tumor cells char-
acterized by vesicular nuclei with nucleoli and acido-
philic cytoplasm (Hematoxylin & eosin stain, original 
magnification, 200×).
Figure 3 Magnetic resonance image of patient pre-
sented in Case 3. Sagittal T1-weighted image with gado-
linium enhancement disclosed a nonenhanced tumor in the 
lower posterior portion of the anterior pituitary gland.
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levels are negatively correlated with plasma cortisol 
levels.17,18 The overproduction of cortisol, which 
has mineralocorticoid effects, has been proposed to 
explain such phenomena.19 Another possible mech-
anism may involve increased deoxycorticosterone or 
corticosterone levels, as a result of chronic ACTH 
stimulation.20 Our experience demonstrated that 
hypokalemia may not be a rare finding in children 
with Cushing’s disease.
The diagnosis of Cushing’s disease is based on the 
clinical suspicion and biochemical confirmation of 
hypercortisolism. Lack of a diurnal rhythm in serum 
cortisol levels is the most sensitive index for hy-
percortisolism, especially in children.6,9,21,22 More 
than 50% of children with Cushing’s disease have high 
serum cortisol levels in the early morning.3 A rela-
tive resistance to glucocorticoid suppression of ACTH 
secretion has been found in patients with ACTH-
dependent Cushing’s disease.11,21,22 Hypercortisolism 
that can be suppressed by high-dose, but not low-
dose dexamethasone is thus the classical feature 
of this disease.11 All three patients in this report had 
high serum cortisol levels with no diurnal changes. 
Serum cortisol levels were not suppressed by low-
dose dexamethasone in two of these patients (cases 
1 and 3) but serum cortisol levels were suppressed in 
case 2. Such a phenomenon has been reported in 
the literature,6,7,11,21 It confirms that the recom-
mended dosage of dexamethasone for children in 
the low-dose dexamethasone suppression test may 
be too high in some children with Cushing’s dis-
ease. The results of dexamethasone suppression 
tests in children with Cushing’s syndrome should 
thus be interpreted with caution. After careful 
analysis of the above data, imaging studies of the 
pituitary gland should be arranged in patients with 
suspected Cushing’s disease.12 Bilateral inferior 
petrosal sinus samplings with or without ovine cor-
ticotropin-releasing hormone stimulation are rec-
ommended when pituitary lesions are hard to define 
in imaging studies.4,5,9,10,13,14
Transsphenoidal pituitary adenomectomy is the 
treatment of choice in patients with Cushing’s 
disease.3−6,8−10 The signs and symptoms of hypercor-
tisolism usually improve gradually within several 
months following surgery. The hypothalamic-pituitary-
adrenal axis usually recovers between 6 and 12 
months, and substantial catch-up growth may occur.4 
In patients who cannot be cured by the first opera-
tion or who experience recurrence, repeated surgery 
or radiotherapy are considered as second-line treat-
ments.5,23 Diabetes insipidus and hypopituitarism may 
develop after pituitary surgery or radiotherapy.5,23,24 
Under such circumstances, appropriate hormone 
replacement therapy is indicated. In patients with 
growth hormone deficiency, growth hormone ther-
apy will be beneficial in terms of their adult height.9,15
In conclusion, rapid weight gain but retarded 
growth in children is a clue to hypercortisolism. A 
high index of suspicion is important for the early 
and correct diagnosis Cushing’s disease in children.
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